Literature DB >> 3397523

An investigation of the effects of lofepramine, nomifensine, amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving.

I Hindmarch1, C Harrison, C A Shillingford.   

Abstract

Ten healthy, female volunteers took part in a double-blind, placebo-controlled study to investigate the effects of lofepramine 70 mg, lofepramine 140 mg, nomifensine 100 mg, amitriptyline 50 mg and placebo on psychomotor performance related to driving. One subject failed to complete the study for reasons unrelated to the medications. Each subject received each of the treatments in random order at weekly intervals and was then assessed for psychomotor performance, sedation and quality of sleep. Amitriptyline 50 mg served as a positive control producing results consistent with its known sedative properties. In contrast, lofepramine 70 mg and 140 mg and nomifensine 100 mg were generally free from any significant effect on psychomotor performance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397523     DOI: 10.1097/00004850-198804000-00006

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  5 in total

1.  Bupropion normalizes cognitive performance in patients with depression.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  MedGenMed       Date:  2007-01-31

2.  A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers.

Authors:  D B Fairweather; J S Kerr; S Hilton; I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 3.  Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Authors:  Tharaka Dassanayake; Patricia Michie; Gregory Carter; Alison Jones
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

4.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 5.  Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  S G Lancaster; J P Gonzalez
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.